Page 1 of 1

Biogen Idec gains commercial rights of Tysabri from Elan

Posted: Thu Apr 04, 2013 12:27 am
by MSUK
Biogen Idec gains commercial rights of Tysabri from Elan Corporation

Biogen Idec has completed its purchase of Elan Corporation’s interest in Tysabri (natalizumab) and has gained full strategic, commercial and decision-making rights of Tysabri. The transaction was originally announced on February 6, 2013....................Read More - http://www.ms-uk.org/index.cfm/tysabri

Re: Biogen Idec gains commercial rights of Tysabri from Elan

Posted: Thu Apr 04, 2013 4:37 am
by HarryZ
squiffy2 wrote:Biogen Idec gains commercial rights of Tysabri from Elan Corporation

Biogen Idec has completed its purchase of Elan Corporation’s interest in Tysabri (natalizumab) and has gained full strategic, commercial and decision-making rights of Tysabri. The transaction was originally announced on February 6, 2013....................Read More - http://www.ms-uk.org/index.cfm/tysabri
Makes you wonder if Elan knows something about Tysabri that we don't and got out after making as much money as they could.